Evidence map›Paper›PMID 40696946›Full record

ArticleJournal of biochemical and molecular toxicology2025

Antineoplastic Effects of Thymoquinone on Pancreatic Atypical Acinar Cell Foci Treated With Azaserine.

Hasan Yildiz, Başak Hartavi

Abstract read
In one paragraph

Article in Journal of biochemical and molecular toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hasan YildizBiology Department, Faculty of Arts and Sciences, Hatay Mustafa Kemal University, Hatay, Turkey.ORCID https://orcid.org/0000-0001-5486-4005
Başak HartaviGraduate School of Natural and Applied Sciences, Hatay Mustafa Kemal University, Hatay, Turkey.ORCID https://orcid.org/0009-0002-3646-6913

Funding

The authors received no specific funding for this work.
6 · The paper itself

Abstract

The antineoplastic effects of thymoquinone (TQ) (which has antioxidant and anticarcinogenic effects) on neoplastic changes (atypical acinar cell foci, AACF) induced by azaserine were investigated, for the first time. Rats were randomly divided into five groups of 10 rats each (Cont, Tim, Az, AzTim1, and AzTim2). The Cont group was fed only with a standard diet. TQ (50 mg/L) was given orally (P.O.) to the Tim, AzTim1, and AzTim2 groups. TQ was given to Tim and AzTim1 after the first month, while AzTim2 group rats were given after the third month of azaserine injection, when AACFs began to form. Azaserine was injected intraperitoneally (i.p.) (30 mg/kg bw) to 2-weeks-old Wistar albino male rats in the Az, AzTim1, and AzTim2 groups. AACF load were observed to be statistically significantly higher in all categories in the Az group compared to the Cont group (p < 0.05). AACF load were statistically significantly lower in all TQ groups (AzTim1 and AzTim2) compared to the Az group and it was demonstrated with TQ-containing diet administration. This decrease indicates the antineoplastic effect of TQ on AACF and supports previous studies.

Indexed as

Acinar CellsAntineoplastic AgentsBenzoquinonesPancreatic NeoplasmsAnimalsMaleRatsRats, WistarAntineoplastic AgentsBenzoquinonesthymoquinoneAACFantineoplastic effectazaserineexocrine pancreasratthymoquinone

Identifiers

PMID40696946
PMCPMC12284612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.